Comment on NATSEM's report on the economic and societal cost of Alzheimer disease in Australia

被引：0
|
作者：
Valenzuela, Michael [1 ]
机构：
[1] UNSW Sydney, Ctr Hlth Brain Ageing CHeBA, Sydney, NSW, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2022年 / 216卷 / 10期
关键词：
D O I：
10.5694/mja2.51521
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [1] The cost of Alzheimer's disease: an economic tricky situation
    Joel, ME
    [J]. M S-MEDECINE SCIENCES, 2002, 18 (6-7): : 757 - 759
  • [2] Societal consequences of Alzheimer's disease
    Michel, J. -P.
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (03): : 214 - 216
  • [3] The economic cost of Alzheimer's disease to a state Medicaid program
    Menzin, J
    Lang, K
    Friedman, M
    [J]. NEUROLOGY, 1999, 52 (06) : A8 - A9
  • [4] Annual economic cost of informal care in Alzheimer's disease
    Turro-Garriga, Oriol
    Lopez-Pousa, Secundino
    Vilalta-Franch, Joan
    Turon-Estrada, Antoni
    Pericot-Nierga, Imma
    Lozano-Gallego, Manuela
    Hernandez-Ferrandiz, Marta
    Soler-Cors, Olga
    Planas-Pujol, Xenia
    Monserrat-Vila, Silvia
    Garre-Olmo, Josep
    [J]. REVISTA DE NEUROLOGIA, 2010, 51 (04) : 201 - 207
  • [5] Economic cost of Alzheimer disease in Israel
    Beeri, MS
    Werner, P
    Adar, Z
    Davidson, M
    Noy, S
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 (02): : 73 - 80
  • [6] The Economic and Societal Burden of Alzheimer Disease: Managed Care Considerations
    Skaria, Anita Pothen
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (10): : S188 - S196
  • [7] The Societal Cost of China's Rapid Economic Growth
    Knight, John
    [J]. ASIAN ECONOMIC PAPERS, 2016, 15 (02) : 138 - 159
  • [8] Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective
    Hornberger, John
    Michalopoulos, Steven
    Dai, Minghan
    Andrade, Paula
    Dilla, Tatiana
    Happich, Michael
    [J]. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 (02): : 63 - 73
  • [9] Comment on the preliminary report of the IQWiG "Cholinesterase inhibitor in Alzheimer's disease"
    Gogol, Manfred
    Luettje, Dieter
    Werner, Hansjoerg
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2007, 40 (03): : 192 - 194
  • [10] Economic impact of Alzheimer's disease in the United Kingdom -: Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease
    Souêtre, E
    Thwaites, RMA
    Yeardley, HL
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 : 51 - 55
12345